Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Revenue

In the year 2025, Vertex Pharmaceuticals had annual revenue of $12.00B with 8.90% growth. Vertex Pharmaceuticals had revenue of $3.19B in the quarter ending December 31, 2025, with 9.55% growth.

• Revenue (ttm): $12.00B
• Revenue Growth: +8.90%
• P/S Ratio: 9.35
• Revenue / Employee: $1,875,203
• Employees: 6,400
• Market Cap: 112.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.00B	981.20M	8.90%
Dec 31, 2024	11.02B	1.15B	11.66%
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%
Dec 31, 2019	4.16B	1.12B	36.59%
Dec 31, 2018	3.05B	558.95M	22.46%
Dec 31, 2017	2.49B	786.47M	46.20%
Dec 31, 2016	1.70B	669.84M	64.89%
Dec 31, 2015	1.03B	451.93M	77.86%
Dec 31, 2014	580.42M	-631.57M	-52.11%
Dec 31, 2013	1.21B	-315.06M	-20.63%
Dec 31, 2012	1.53B	116.41M	8.25%
Dec 31, 2011	1.41B	1.27B	883.91%
Dec 31, 2010	143.37M	41.48M	40.71%
Dec 31, 2009	101.89M	-73.62M	-41.94%
Dec 31, 2008	175.50M	-23.51M	-11.81%
Dec 31, 2007	199.01M	-17.34M	-8.02%
Dec 31, 2006	216.36M	55.47M	34.47%
Dec 31, 2005	160.89M	-	-